1-7 of 7
urochordata
Close
Sort by
Journal Articles

Aplidin (Plitidepsin) Regulates Viability and Function of Myeloma Cells and Bone Cells in Combination with Other Anti-MM Drugs

Jesus Delgado-Calle, PhD, Emily G Atkinson, Jessica Nelson, Noriyoshi Kurihara, DDS, PhD, Carlos Galmarini, David David Roodman, MD PhD, Teresita Bellido
Journal: Blood
Blood (2017) 130 (Supplement 1): 3065.
https://doi.org/10.1182/blood.V130.Suppl_1.3065.3065
Published: 2017
Journal Articles

Plitidepsin Inhibits the Growth of Cells Harboring JAK2V617F Mutation.

Costanza Bogani, PhD, Paola Guglielmelli, MD, Niccolò Bartalucci, BSc, Miguel Aracil, MD, Maria Fe Paz, PhD, Alberto Bosi, MD, Alessandro M. Vannucchi, MD
Journal: Blood
Blood (2009) 114 (22): 3907.
https://doi.org/10.1182/blood.V114.22.3907.3907
Published: 2009
Journal Articles

The Marine Tunicate-Derived Cyclic Depsipeptide Aplidin Restores Functional Hematopoiesis in the Marrow of the Gata1 low Mouse Model of Myelofibrosis.

Maria Verrucci, Ph.D, Alessandro Pancrazzi, PhD, Fabrizio Martelli, Ph.D, Paola Guglielminelli, Miguel Aracil, Maria Zingariello, Ph.D, Emanuela D'Amore, Jose Jimeno, Alessandro M. Vannucchi, MD, Anna Rita Migliaccio, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 3914.
https://doi.org/10.1182/blood.V114.22.3914.3914
Published: 2009
Journal Articles

Final Results of a Phase II Trial with Plitidepsin (Aplidin) Alone and in Combination with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Maria-Victoria Mateos, Mª Teresa Cibeira, Paul Richardson, Joan Blade, Felipe Prosper, MD, Albert Oriol, Javier de la Rubia, MD, Adrian Alegre, MD, Juan José Lahuerta, MD, PhD, Ramón García-Sanz, MD, PhD, Constantine S. Mitsiades, MD, PhD, Jose Espinoza, MD, Kenneth C. Anderson, J.F. San Miguel
Journal: Blood
Blood (2008) 112 (11): 3700.
https://doi.org/10.1182/blood.V112.11.3700.3700
Published: 2008
Journal Articles

Antimyeloma Efficacy of Plitidepsin (Aplidin®): From Bench to the Bedside.

Enrique M. Ocio, Constantine Mitsiades, M. Victoria Mateos, Patricia Maiso, Faustino Mollinedo, Mercedes Garayoa, Consuelo Gajate, Joan Blade, Felipe Prosper, Juan José Lahuerta, Nicholas Mitsiades, Ciaran J. McMullan, Nikhil C. Munshi, Teru Hideshima, Dharminder Chauhan, Carmen Cuevas, Pablo Avilés, Glynn Faircloth, Paul G. Richardson, Atanasio Pandiella, Kenneth C. Anderson, J.F. San Miguel
Journal: Blood
Blood (2007) 110 (11): 1178.
https://doi.org/10.1182/blood.V110.11.1178.1178
Published: 2007
Journal Articles

Preliminary Report from an Exploratory Phase II Trial with Plitidepsin (Aplidin®) in Patients with Refractory/Relapsed Multiple Myeloma.

M. V. Mateos, MD, J. Blade, MD, F. Prosper, MD, J. J. Lahuerta, MD, R. Garcia-Sanz, MD, M. Cibeira, MD, L. Rusiñol, MD, F. Escalante, MD, M. Ruiz, MD, P. G. Richardson, MD, J. F. San Miguel, MD
Journal: Blood
Blood (2005) 106 (11): 2569.
https://doi.org/10.1182/blood.V106.11.2569.2569
Published: 2005
Journal Articles

Preclinical Investigations Demonstrate Effectiveness of Aplidin in Acute Leukemias and Lymphomas and Provide the Basis for Further Clinical Studies.

Debabrata Banerjee, Ph.D., Guray Saydam, M.D., Lata G. Menon, Ph.D., Giuseppe S.A. Longo, M.D., Daniel Medina, Ph.D., Roger Strair, M.D., Ph.D., Jose Jimeno, M.D., Eugenio Erba, Ph.D., Alberto Grossi, M.D., Gertjan J.. L. Kapers, M.D., Norea Martinez, Ph.D., Joseph Bertino, M.D.
Journal: Blood
Blood (2004) 104 (11): 4496.
https://doi.org/10.1182/blood.V104.11.4496.4496
Published: 2004